FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's supplemental application for a generic ezetimibe and simvastatin combination product, expanding access to this lipid-lowering therapy as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• EZETIMIBE AND SIMVASTATIN (ezetimibe and simvastatin)

Snippet

SUPPL AP for EZETIMIBE AND SIMVASTATIN (EZETIMIBE AND SIMVASTATIN)